# FINZALA
> **ANDA210087** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2020-04-07
## Drug
- **FDA Application Number:** ANDA210087
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FINZALA
- **Generic name:** NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
- **Active ingredients:** ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS USA INC
- **Manufacturer:** Teva Pharmaceuticals USA, Inc.
- **First approval:** 2020-04-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210087)
---
*MORVS · CC0 1.0*